As shown earlier, after adding the 1693 samples from our case-control study, the cumulative sample size for the Asian sample entered the futility area defined by TSA (Figure 2), enabling 95% confidence to declare that there is no significant correlation between PPARG Pro12Ala and CKD. The gene discussed is PPARG; the disease is chronic kidney disease.